The agenda for this year’s annual PhRMA conference includes in-depth analysis by industry, advocacy, research, and government leaders to help highlight the scientific, health, regulatory and investment challenges and opportunities faced by the pharmaceutical industry. Speakers include PhRMA CEO John Castellani, Eli Lilly Chairman, President and CEO John Lechleiter, Celgene Chairman and CEO Robert Hugin, NIH Director Francis S. Collins, and New York Times bestselling author Daniel Pink. More information is here.